Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device

• Status: Completed
• Trial end date: 2012-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Relative Bioavailability Comparison study

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Antares Pharma Inc.
• Treatments: Methotrexate

Criteria

Inclusion Criteria:

• Male or female patients ≥18 years of age, diagnosed with Rheumatoid Arthritis

Exclusion Criteria:

• Pregnant females

• Any other clinically significant disease or disorder which, in the opinion of the investigator might put the subject at risk